The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>KCE</strong> Reports 120 Plasma 123<br />
For other immune deficiencies treated <strong>in</strong> your centre <strong>in</strong> 2008 <strong>with</strong> <strong>in</strong>travenous IG<br />
Indications Total number<br />
patients followed<br />
Myeloma<br />
Chronic lymphocytic<br />
leukemia<br />
Prevention of <strong>in</strong>fections <strong>in</strong><br />
transplant<br />
Other immune deficiencies<br />
that required IG (please<br />
specify)<br />
Number IVIG<br />
treatments given<br />
<strong>in</strong> 2008<br />
Average dose per<br />
treatment <strong>in</strong> g/kg<br />
(or usual dose)<br />
Comments:…………………………………………………………………………………..<br />
4. For other <strong>in</strong>dications treated <strong>in</strong> your centre <strong>in</strong> 2008 <strong>with</strong> <strong>in</strong>travenous IG<br />
Indications Number IVIG treatments<br />
given <strong>in</strong> 2008<br />
Idiopathic thrombocytopenic<br />
purpura <strong>in</strong> children<br />
Idiopathic thrombocytopenic<br />
purpura <strong>in</strong> adults<br />
Guilla<strong>in</strong> Barré syndrome<br />
Kawasaki syndrome<br />
Toxic shock syndrome<br />
Infections <strong>in</strong> neonates<br />
Others:………………<br />
General comments:<br />
Do you w<strong>is</strong>h to receive the <strong>KCE</strong> <strong>report</strong> once publ<strong>is</strong>hed?<br />
(it will also <strong>available</strong> be <strong>available</strong> on our website www.kce.fgov.be)<br />
Thank you for your time!<br />
Average dose per treatment<br />
<strong>in</strong> g/kg (or usual dose)